Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Memórias do Instituto Oswaldo Cruz |
Texto Completo: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000400001 |
Resumo: | Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature. |
id |
FIOCRUZ-4_4f4b7dd34914b93c7de897961b81ff9d |
---|---|
oai_identifier_str |
oai:scielo:S0074-02762009000400001 |
network_acronym_str |
FIOCRUZ-4 |
network_name_str |
Memórias do Instituto Oswaldo Cruz |
spelling |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a reviewsepsisseptic shockglucocorticoidstherapeuticsbacterial infectionsCorticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature.Instituto Oswaldo Cruz, Ministério da Saúde2009-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000400001Memórias do Instituto Oswaldo Cruz v.104 n.4 2009reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762009000400001info:eu-repo/semantics/openAccessJapiassú,André MSalluh,Jorge IFBozza,Patrícia TBozza,Fernando ACastro-Faria-Neto,Hugo Ceng2020-04-25T17:50:29Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:16:13.374Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue |
dc.title.none.fl_str_mv |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
title |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
spellingShingle |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review Japiassú,André M sepsis septic shock glucocorticoids therapeutics bacterial infections |
title_short |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
title_full |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
title_fullStr |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
title_full_unstemmed |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
title_sort |
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review |
author |
Japiassú,André M |
author_facet |
Japiassú,André M Salluh,Jorge IF Bozza,Patrícia T Bozza,Fernando A Castro-Faria-Neto,Hugo C |
author_role |
author |
author2 |
Salluh,Jorge IF Bozza,Patrícia T Bozza,Fernando A Castro-Faria-Neto,Hugo C |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Japiassú,André M Salluh,Jorge IF Bozza,Patrícia T Bozza,Fernando A Castro-Faria-Neto,Hugo C |
dc.subject.por.fl_str_mv |
sepsis septic shock glucocorticoids therapeutics bacterial infections |
topic |
sepsis septic shock glucocorticoids therapeutics bacterial infections |
dc.description.none.fl_txt_mv |
Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature. |
description |
Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-07-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000400001 |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000400001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0074-02762009000400001 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Instituto Oswaldo Cruz, Ministério da Saúde |
publisher.none.fl_str_mv |
Instituto Oswaldo Cruz, Ministério da Saúde |
dc.source.none.fl_str_mv |
Memórias do Instituto Oswaldo Cruz v.104 n.4 2009 reponame:Memórias do Instituto Oswaldo Cruz instname:Fundação Oswaldo Cruz instacron:FIOCRUZ |
reponame_str |
Memórias do Instituto Oswaldo Cruz |
collection |
Memórias do Instituto Oswaldo Cruz |
instname_str |
Fundação Oswaldo Cruz |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
repository.name.fl_str_mv |
Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz |
repository.mail.fl_str_mv |
|
_version_ |
1669937705466724352 |